Chemical Name: 5-[2-Ethoxy-5-[(4-ethyl-1-piperazinyl)sulfonyl]-3-pyridinyl]-3-ethyl-2,6-dihydro-2-(2-methoxyethyl)-7H-pyrazolo[4,3-d]pyrimidin-7-one benzenesulfonate
Biological ActivityPotent PDE5 inhibitor (IC50 = 1.23 nM). Shows >100-fold selectivity for PDE5 over PDE6. Orally bioavailable.
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
The discovery of UK-369003, a novel PDE5 inhibitor with the potential for oral bioavailability and dose-proportional pharmacokinetics.
Rawson et al.
Emerging drugs for the treatment of benign prostatic obstruction.
Hashim and Abrams
Citation for Gisadenafil besylate
The citations listed below are publications that use Tocris products. Selected citations for Gisadenafil besylate include:
1 Citation: Showing 1 - 1
No product specific FAQs exist for this product, however you mayView all Small Molecule FAQs
Reviews for Gisadenafil besylate
There are currently no reviews for this product. Be the first to review Gisadenafil besylate and earn rewards!
Have you used Gisadenafil besylate?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image